Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Guangdong Pharmaceutical UniversityActive in the last 2 years

Rongxin Zhang

Matched on ORCID iD 0000-0002-4083-374X; OpenAlex author ID A5007708850. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 9)
Trials
0
Grants
0
Labs led
2
Collaborators
9
Papers, trials and grants by year

2014: 2 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 9

  1. Piperine Inhibits the Immune Checkpoint CD47 to Enhance Immunity Against Pancreatic Cancer. Last author DOI 10.1002/ptr.70110↗
  2. Metabolic reprogramming of drug resistance in pancreatic cancer: mechanisms and effects. Last author DOI 10.1016/j.mam.2025.101368↗
  3. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer. Last author DOI 10.1016/j.intimp.2021.107822↗
  4. Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity. Last author DOI 10.1136/jitc-2019-000253↗
  5. miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer. Last author DOI 10.3389/fimmu.2020.00890↗
  6. Apolipoprotein A-I Mimetic Peptide L-4F Suppresses Granulocytic-Myeloid-Derived Suppressor Cells in Mouse Pancreatic Cancer. Last author DOI 10.3389/fphar.2020.00576↗
  7. Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression. Last author DOI 10.18632/oncotarget.21157↗
  8. Embelin inhibits pancreatic cancer progression by directly inducing cancer cell apoptosis and indirectly restricting IL-6 associated inflammatory and immune su… Last author DOI 10.1016/j.canlet.2014.08.011↗
  9. Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling. Last author DOI 10.18632/oncotarget.1963↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qing Xi · 5 shared papers, 2020–2026 · strength 0.86
  2. Xue He · 1 shared paper, 2026 · strength 0.30
  3. Jinyi Zhang · 1 shared paper, 2025 · strength 0.25
  4. Li Yan · 2 shared papers, 2020–2021 · strength 0.23
  5. Chengzhi Wang · 2 shared papers, 2020–2021 · strength 0.21
  6. Meiyu Peng · 3 shared papers, 2014–2020 · strength 0.20
  7. Qi Zhang · 2 shared papers, 2017–2020 · strength 0.17
  8. Ying Chen · 1 shared paper, 2021 · strength 0.12
  9. Bingqing Huang · 2 shared papers, 2014 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.